Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-10 Purchase | 2024-05-13 08:47 am | Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer | 1,113 | $6.32 | $7,034 | 1,493,068 (Direct) | View |
| 2023-03-21 Purchase | 2023-03-22 08:30 am | Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer | 420 | $11.99 | $5,036 | 1,361,955 (Direct) | View |
| 2023-03-15 Purchase | 2023-03-17 08:31 am | Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer | 670 | $10.71 | $7,176 | 1,361,535 (Direct) | View |
| 2022-12-21 Purchase | 2022-12-22 08:30 am | Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer | 500 | $7.65 | $3,825 | 1,245,865 (Direct) | View |
| 2022-11-16 Purchase | 2022-11-18 08:30 am | Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer | 300 | $7.15 | $2,145 | 1,245,365 (Direct) | View |
| 2022-09-23 Purchase | 2022-09-27 08:45 am | Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer | 220 | $7.87 | $1,731 | 1,245,065 (Direct) | View |
| 2022-09-02 Purchase | 2022-09-06 08:00 am | Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer | 404 | $8.31 | $3,357 | 1,244,845 (Direct) | View |
| 2022-08-31 Purchase | 2022-09-02 08:30 am | Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer | 3,006 | $8.07 | $24,258 | 1,244,441 (Direct) | View |
| 2022-05-20 Purchase | 2022-05-23 08:31 am | Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer | 300 | $16.54 | $4,962 | 1,241,435 (Direct) | View |
| 2022-05-16 Purchase | 2022-05-18 08:31 am | Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer | 242 | $19.44 | $4,704 | 1,241,135 (Direct) | View |
| 2022-05-12 Purchase | 2022-05-13 08:30 am | Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer | 1,278 | $15.85 | $20,255 | 1,240,893 (Direct) | View |
| 2022-02-04 Purchase | 2022-02-08 6:00 pm | Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Development Officer | 2,946 | $3.4058 | $10,034 | 1,179,615 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-03 Option Award | 2024-01-05 4:30 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer | 130,000 | $0 | 1,491,955 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-13 5:04 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer | 115,000 | $0 | 1,360,865 (Direct) | View |
| 2022-04-01 Option Award | 2022-04-05 4:46 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer | 60,000 | $0 | 1,239,615 (Direct) | View |
Ownership | 2022-02-08 08:37 am | N/A N/A | Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Development Officer | 0 | $0 | 1,176,669 (Direct) | View |